Latest Aquaculture News

Clean Seas Seafood Limited has entered a binding scheme of arrangement with Yumbah Aquaculture, offering shareholders a 52% premium cash exit or a speculative scrip alternative. The Independent Board Committee recommends approval, with a shareholder meeting set for June 23.

Seafarms Group has completed a $6.83 million sale and leaseback deal with Mainstream Aquaculture, ensuring continued prawn farming operations at Cardwell through early 2026 and beyond. This strategic move supports ongoing growth amid strong domestic and international demand.

Rare Foods Australia has secured shareholder approval to voluntarily delist from the ASX, while implementing significant cost reductions and achieving record growth in its Subsea Estate wine brand.

BPH Global Ltd has raised $609,000 through a targeted placement and made significant strides in its Indonesian seaweed venture, including binding offtake agreements and R&D breakthroughs on mineral extraction.

Carnegie Clean Energy has advanced its ACHIEVE Programme with a key contract for CETO deployment at the Basque Marine Energy Platform, securing milestone payments exceeding €1.5 million and launching a new Investor Hub to enhance shareholder engagement.

Sparc Technologies has progressed to Stage 2 of its Sparc Hydrogen joint venture with pilot plant commissioning slated for mid-2025, while also securing its first patent for photocatalytic water splitting technology in Morocco. Concurrently, its graphene-based additive ecosparc® demonstrates promising field trial results, underpinning commercial momentum.

Murray Cod Australia Ltd reports a remarkable 192% biomass increase, setting the stage for expanded domestic and international sales from May 2025. The company also advances sustainability certifications and strengthens its board to support growth.

Sprintex Limited has advanced its commercial and technological milestones with major European and Indian orders, breakthrough energy efficiency validation, and a successful A$3.25 million equity raise, positioning the company for accelerated growth.

Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

Rare Foods Australia reports an 18% biomass increase and $440k in cost savings, while launching its Subsea Estate brand and securing a $2.1M R&D refund to support growth.